XV International Symposium on Atherosclerosis 2009

Highlights

We are very pleased to present the following Highlights based on several of the sessions held in conjunction with the XV International Symposium on Atherosclerosis (Boston, MA, USA June 14-18, 2009):

"Should HDL Be a Target of Therapy," held on June 16, 2009, during the ISA2009. This educational activity was supported by an independent educational grant from Roche. Please click on the following link www.isa2009.org/HDLHighlights.pdf for the Highlights of the educational session: "Should HDL Be a Target of Therapy." If you wish to receive a hard copy in the mail, please provide us with a complete postal address.

"Risk Factors for Atherosclerosis" held as a satellite meeting on June 19, 2009 in Framingham, MA, USA, following the ISA2009. This educational activity was supported in part by an independent educational grant from AstraZeneca Pharmaceuticals LP and Schering-Plough. Please click on the following link www.isa2009.org/RiskFactorsHighlights.pdf for the Highlights of the satellite symposium: "Risk Factors for Atherosclerosis."

"High-Density Lipoproteins and Atherosclerosis" held as a satellite meeting on June 19-20, 2009 in Newport, RI, USA, following the ISA2009. This educational activity was supported by an independent educational grant from Roche. Please click on the following link for the Highlights of the satellite symposium: "High-Density Lipoproteins and Atherosclerosis."

Coming Soon

"The Biology of Atherosclerosis" held as a satellite meeting on June 12-13, 2009 in Boston, MA, USA, prior to the ISA2009. This educational activity was supported in part by an independent educational grant from AstraZeneca Pharmaceuticals LP and Schering-Plough.